Epithalon
Also known as Epitalon · Epithalone · AEDG
New
Reconstitution & dosing guide
10 mg · 50 mg vial sizes — research phases, recon steps, and a live unit calculator.
Available sizes & price
Catalog only10mg x 10 vials
Epithalon (ET10) · Not in current stock
$25 / vial
50mg x 10 vials
Epithalon (ET50) · Not in current stock
$60 / vial
Prices per vial · Research use only · Not medical advice.
Synthetic tetrapeptide from Russian bioregulator research, claimed to influence telomerase and circadian rhythms.
How to picture it
Picture the ends of your chromosomes as the plastic tips on shoelaces (telomeres). Every cell division wears those tips down a little; when they get too short, the cell often stops dividing cleanly. Epithalon is studied as a short signal that may encourage telomerase — the tip-repair crew — and also ties into pineal and circadian chemistry. The educational picture is two aging control panels: chromosome-end maintenance and the sleep/clock axis, not a overnight "age reverse" switch. Evidence is strongest in cell and bioregulator literature rather than large Western longevity trials.
Research focus & benefits
- Telomerase and telomere research interest
- Pineal and circadian pathway studies
- Cellular aging model literature
- Bioregulator tradition research context
Benefits describe research interest and pathway rationale — not guaranteed outcomes or medical advice. Research use only.
Overview
Epithalon (often spelled Epitalon) is a synthetic tetrapeptide based on epithalamin research associated with the pineal gland. Longevity communities discuss telomere length, melatonin normalization, and cancer-prevention narratives. Formal Western clinical evidence is limited relative to the hype.
Mechanism
Proposed activation of telomerase in some cell studies; pineal/melatonin axis bioregulation claims from Khavinson-school literature.
Research uses
- Telomere/telomerase cell studies
- Aging and pineal bioregulator research
- Circadian rhythm discussions
Research dosing notes
Community courses of daily injections for 10–20 days, repeated periodically, are frequently described — not validated clinical standards.
Half-life / kinetics
Short; course-based protocols common in communities
Common research routes
Reported considerations
- Generally mild anecdotal reports
- Injection-site irritation
- Unknown long-term Western safety database
Contraindications / cautions
- Active cancer without oncology guidance
- Pregnancy
- Expectation of proven life extension
Common research stacks
- Thymalin / Thymosin Alpha-1 (bioregulator stacks)
- Sleep hygiene
Legal / access note
Not FDA-approved as a longevity drug; research/bioregulator market product.